Lazard Asset Management LLC Ptc Therapeutics, Inc. Transaction History

Lazard Asset Management LLC

  • $61.8 Billion
  • Q4 2024

A detailed history of Lazard Asset Management LLC transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Lazard Asset Management LLC holds 45,647 shares of PTCT stock, worth $2.37 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
45,647
Previous 11,578 294.26%
Holding current value
$2.37 Million
Previous $429,000 380.19%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$34.99 - $52.07 $1.19 Million - $1.77 Million
34,069 Added 294.26%
45,647 $2.06 Million
Q3 2024

Nov 14, 2024
SELL
$30.39 - $37.66 $215,221 - $266,708
-7,082 Reduced 37.95%
11,578 $429,000
Q2 2024

Aug 14, 2024
BUY
$24.69 - $40.12 $300,131 - $487,698
12,156 Added 186.9%
18,660 $570,000
Q1 2024

May 14, 2024
BUY
$24.15 - $31.95 $114,495 - $151,474
4,741 Added 268.92%
6,504 $188,000
Q4 2023

Feb 14, 2024
SELL
$18.07 - $29.37 $65,720 - $106,818
-3,637 Reduced 67.35%
1,763 $48,000
Q3 2023

Nov 14, 2023
BUY
$22.41 - $41.99 $23,821 - $44,635
1,063 Added 24.51%
5,400 $121,000
Q2 2023

Aug 14, 2023
BUY
$40.4 - $59.1 $121,886 - $178,304
3,017 Added 228.56%
4,337 $176,000
Q1 2023

May 15, 2023
SELL
$38.16 - $48.86 $44,189 - $56,579
-1,158 Reduced 46.73%
1,320 $63,000
Q4 2022

Feb 14, 2023
BUY
$33.53 - $54.79 $44,460 - $72,651
1,326 Added 115.1%
2,478 $94,000
Q3 2022

Nov 14, 2022
BUY
$41.85 - $53.85 $48,211 - $62,035
1,152 New
1,152 $57,000
Q2 2022

Aug 09, 2022
SELL
$25.6 - $45.23 $644,915 - $1.14 Million
-25,192 Closed
0 $0
Q1 2022

May 13, 2022
BUY
$33.33 - $44.6 $774,922 - $1.04 Million
23,250 Added 1197.22%
25,192 $939,000
Q4 2021

Feb 09, 2022
BUY
$35.36 - $41.86 $68,669 - $81,292
1,942 New
1,942 $77,000
Q3 2021

Nov 15, 2021
SELL
$37.01 - $44.74 $10,436 - $12,616
-282 Closed
0 $0
Q2 2021

Aug 12, 2021
SELL
$37.95 - $49.37 $111,231 - $144,703
-2,931 Reduced 91.22%
282 $11,000
Q1 2021

May 14, 2021
SELL
$46.8 - $68.92 $319,222 - $470,103
-6,821 Reduced 67.98%
3,213 $152,000
Q4 2020

Feb 11, 2021
BUY
$47.96 - $67.64 $481,230 - $678,699
10,034 New
10,034 $612,000
Q2 2020

Aug 13, 2020
SELL
$42.56 - $54.98 $67,244 - $86,868
-1,580 Closed
0 $0
Q1 2020

May 14, 2020
BUY
$32.37 - $59.36 $51,144 - $93,788
1,580 New
1,580 $70,000
Q4 2019

Feb 13, 2020
SELL
$32.22 - $50.07 $11,148 - $17,324
-346 Closed
0 $0
Q3 2019

Nov 14, 2019
SELL
$33.82 - $48.17 $301,978 - $430,109
-8,929 Reduced 96.27%
346 $11,000
Q4 2015

Jul 24, 2019
SELL
N/A
-6,234 Reduced 40.2%
9,275 $300,000
Q3 2015

Jul 15, 2019
BUY
N/A
15,509
15,509 $414,000

Others Institutions Holding PTCT

# of Institutions
249
Shares Held
76.8M
Call Options Held
158K
Put Options Held
401K
View Full List

About PTC THERAPEUTICS, INC.

PTCT Quotes by TradingView
  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $3.71B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email